Dr. Rae Bacharach discusses trends in medical clerkships in neurology.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses early-onset Alzheimer Disease. To learn more, read the article "Early-onset Alzheimer Disease and Its Variants" by Dr. Mario F. Mendez in that issue.

Dr. Jenny Linnoila discusses the main takeaways from her podcast interview and paper on a mouse model of anti-NMDA receptor post-herpes simplex encephalitis. 

Pam Belluck of the New York Times discusses He Jiankui, gene editing and CRISPR. Read one of the articles on the issue here: https://www.nytimes.com/2019/04/14/health/gene-editing-babies.html

Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.

Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day’s article, “Reversible Dementias,” in the February 2019 Dementia issue of Continuum.

Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.

Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses behavioral-variant frontotemporal dementia. To learn more, read the article “Behavioral Variant Frontotemporal Dementia” by Dr. William W. Seeley in that issue.

Dr. Mathias Buron discusses the takeaways from his paper the comparative effectiveness of teriflunomide and dimethyl fumarate.